The Medical Radiation Shielding Market is expected to grow from USD 1.340 billion in 2025 to USD 1.721 billion in 2030, at a CAGR of 5.14%.
While the radiation doses utilized in image-guided procedures are generally considered low, there have been instances where significant effects of chronic low-dose radiation exposure to the procedural staff have occurred. Moreover, an increment in brain cancer, an increased incidence of skin, thyroid, breast cancers, and melanomas, a higher incidence of stroke and atherosclerotic disease, an increased risk of developing cataracts, decreased memory and verbal fluency, and a higher frequency of chromosomal abnormalities in those who performed fluoroscopically-guided interventional procedures have been observed.
Moreover, a host of other medical procedures make use of radiation that requires shielding. Thus, the medical radiation shielding market has been witnessing an increasing rate of investment, innovation, and development of products. Currently, the medical staff is at high risk due to increasing exposure to radiation. To avoid the risk, the physicians must wear lead gowns to protect parts of their organs, but the bulky gowns are quite painful on the back, which is a common complaint among doctors who practice in these fields of medicine. Furthermore, because of the radiation that enters their eyes, the majority of them develop cataracts. Also, because their heads are not shielded, they are more likely to develop brain tumours than the general population. To tackle this issue several organizations are developing new offerings. For instance, in India, Advanced Materials and Processes Research Institute (CSIR-AMPRI) developed lead-free radiation shielding tiles, that prevent radiation from leaks without the use of lead tiles. Of the product number of tiles, certain numbers of tiles have been installed of which 2600 tiles have been installed at Saideep Hospital, Ahmednagar in Maharashtra in three X-Ray rooms, a CT Scan Room, and a Cathlab. The Atomic Energy Regulatory Board of the Government of India has approved the shielding effectiveness of CSIR-AMPRI tiles. Furthermore, there is a permissible limit put in place by various governments across different nations. However, prolonged exposure takes a toll on the health of medical professionals and radiation experts, further developing into cancer in many cases.
The aforementioned is an example of the growing number of deaths caused by malignant neoplasms in Singapore, to suggest a national perspective. Thus, the number of diagnostic imaging centers has increased significantly during the past few years due to the increasing prevalence of cancer, adding impetus to the market growth. The materials that form the basis of setting up diagnostic chambers are expected to be in high demand during the forecast period. Thus, the need for innovation has also led companies like Radium Incorporated to bring about innovation branded as ClearView Radiation Shielding™ which is claimed to 50$ lighter in weight than lead for a comparable attenuation from higher energy gammas. Additionally, it also protects more efficiently than lead glass. Additionally, it was granted a patent by the US Patent and Trademark Office in May 2019 under U.S. Patent No. 10,262,763. Thus, it can be clearly outlined that the need for medical radiation shielding materials will reach a zenith and the result of the same will lead to exponential medical radiation shielding growth.
Segmentation